FMP
EURONEXT
Affluent Medical SA develops minimally invasive medical devices for the treatment of heart and vascular diseases in France. It develops Kardiozis technology for the treatment of abdominal aortic aneurysm; Kalios and Epygon implants to treat mitral insufficiency; and Artus implant, an implantable electro-mechanical artificial sphincter for the treatment of severe urinary incontinence in women and men. The company was founded in 2011 and is based in Aix-en-Provence, France.
1.88 EUR
0.035 (1.86%)
Valuation Date:
Apr 19, 2024 10:58 AM
Share Price on Valuation Date
$1.88
Stock Beta
0.501
Shares Outstanding
33145200